Skip to content
Home/Companies/Healthcare/Yukin Therapeutics
YT

Yukin Therapeutics

Healthcare·France·Active·7yr hold

Yukin Therapeutics is a healthcare company, headquartered in France.

Entry
2019
Hold
7yr
Status
Active
Est. EV
–

Who owns Yukin Therapeutics?

Yukin Therapeutics is currently owned by AdBio Partners through AFB Seed-Fund (2017 vintage), since 2019.

Hand-verified · updated 2026-05-24

AdBio Partners
Investor
AdBio Partners
AFB Seed-Fund · 2017 · VC

Key facts

HQFrance
SectorHealthcare
StatusActive

More from AFB Seed-Fund

Other portfolio companies in the same fund.

Alderaan Biotechnology
Active
HealthcareFrance· 2020
ARTHEx Biotech
Active
HealthcareSpain· 2020
Kalsiom
Active
HealthcareFrance· 2020
Wellium
Active
HealthcareFrance· 2020
Agomab Therapeutics
Exited 2026
HealthcareBelgium· 2019
to
SparingVision
Active
HealthcareFrance· 2019

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
4ways
Active
ECI PartnersUK
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abcam (exited)
Active
EMV CapitalUK
Data refreshed weekly · Sourced from public filings